Advanced Therapy Access Program
At Oncos Therapeutics we strictly comply with all national and international regulations. We also feel that patients with a life-threatening disease, which progresses or remains persistent after available routine therapies, must have the right to access promising therapies-in-development. Our Advanced Therapy Access Program was started in 2007 in partnership with International Comprehensive Cancer Center Docrates, a state-of-the-art clinic based in Helsinki, Finland. Under the program, almost 300 patients from 20 countries have been treated with our oncolytic viruses.
With the launch of formal clinical studies, the Advanced Therapy Access Program is currently on hold and new patients are unfortunately not received. Please see the Trials page for details on currently active clinical studies.
